Biopharmaceutics and Pharmacokinetics Considerations

• Gebundenes Buch

Produktbeschreibung

Biopharmaceutics and Pharmacokinetics Considerations examines the history of biopharmaceutics and pharmacokinetics. The book provides a biopharmaceutics and pharmacokinetics approach to addressing issues in formulation development and ethical considerations in handling animals. Written by experts in the field, this volume within the Advances in Pharmaceutical Product Development and Research series deepens understanding of biopharmaceutics and pharmacokinetics within drug discovery and drug development. Each chapter delves into a particular aspect of this fundamental field to cover the principles, methodologies and technologies employed by pharmaceutical scientists, researchers and pharmaceutical industries to study the chemical and physical properties of drugs and the biological effects they produce.

Produktdetails

• Verlag: Elsevier Health Sciences
• Seitenzahl: 752
• Erscheinungstermin: 8. Juli 2021
• Englisch
• Abmessung: 238mm x 196mm x 42mm
• Gewicht: 1701g
• ISBN-13: 9780128144251
• ISBN-10: 0128144254
• Artikelnr.: 59315393

Inhaltsangabe

1. Routes of administrations and implication on drug bioavailability
2. Biopharmaceutics and Pharmacokinetics considerations in drug research
3. Bioavailability and bioequivalence research in Product Development
4. Pharmacokinetic characterization of drugs and new product designing
5. Pharmacokinetic Modulation with Particulate Drug Formulations
6. Dose, Dosage regimen and Dose adjustment
7. Implications of Bio-Nanotechnology in neuroscience, tissue engineering
and cancer therapy
8. Physiologic pharmacokinetics models: Application and limitations
9. Chronopharmacokinetics in drug design
10. Drug toxicity and forensic pharmacokinetics
11. Recent advancements in Pharmacogenomics
12. Biocompatibility testing of biomaterials and biologicals
13. Metabolic kinetics
14. Animal handling and ethical considerations
15. Biopharmaceutic and pharmacokinetic aspects of controlled release
systems
16. Degradation of biomaterials in biological environment
17. Safety and long-term toxicity evaluation of polymers used in
Pharmaceutical Product Development: Regulatory considerations
18. Toxicity and toxicokinetic consideration in product development and
drug research
19. Environmental and safety aspects of bio-nanotechnology
20. Toxicity considerations on repetitive accumulation of polymeric
materials